INCYTE CORP

INCY

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
INCY
CIK0000879169
SIC8731
SectorServices
Industry CategoryBusiness Services
Industry GroupServices – Research, Development, Testing Labs

Contact

Address1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
Website incyte.com
Phone3024986700
CEOHerve Hoppenot
Employees2,320

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$4.41 billion
Pre-Tax Income$314.66 million
Net Income$21.27 million
Net Income to Common$21.27 million
EPS$0.20
View All
Balance Sheet
Cash$1.94 billion
Assets$5.75 billion
Liabilities$2.08 billion
Common Equity$3.67 billion
Liabilities & Equity$5.75 billion
View All
Cash Flow Statement
Calculations
NOPAT$11.80 million
EBITDA$287.23 million
Price to Earnings$569.06
Price to Book$3.30
ROE0.47%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

High Growth Tech Stocks in US with Strong Potential for Investors

The United States market has shown positive momentum, rising 1.8% over the last week and 9.5% over the past year, with earnings projected to grow by 14% annually. In this context of robust market performance, identifying high growth tech stocks with strong potential involves looking for companies that demonstrate innovative capabilities and adaptability in a rapidly evolving sector.

Article Link

Incyte to Present at Upcoming Investor Conference

WILMINGTON, Del., May 01, 2025--Incyte (Nasdaq:INCY) announced today that it will present at the 2025 BofA Securities Health Care Conference on Tuesday, May 13, 2025 at 1:40 pm (PDT).

Article Link

Incyte First Quarter 2025 Earnings: Beats Expectations

Incyte ( NASDAQ:INCY ) First Quarter 2025 Results Key Financial Results Revenue: US$1.05b (up 20% from 1Q 2024). Net...

Article Link

Incyte Corp (INCY) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and Strategic ...

Incyte Corp (INCY) reports a 20% revenue increase, driven by strong Jakafi sales and a successful Niktimvo launch, while navigating competitive challenges.

Article Link

INCY Q1 Earnings & Revenues Beat Estimates on Higher Product Sales

Incyte reports better-than-expected first-quarter 2025 results, beating both earnings and revenue estimates, driven by strong Jakafi and Opzelura sales.

Article Link